Clinical Trial Update: Clinical Study of KW-2246 in Patients With Cancer Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating KW-2246 for cancer-related pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• KW-2246

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Pain, Cancer | Phase 2 | Status: COMPLETED